[1] Weinstein LS, Shenker A, Gejman PV, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome[J]. N Engl J Med, 1991, 325(24): 1688-1695. [2] Tobar-Rubin R, Sultan D, Janevska D, et al. Intragenic suppression of a constitutively active allele of Gsα associated with McCune-Albright syndrome[J]. J Mol Endocrinol, 2013, 50(2): 193-201. [3] Lietman SA, Schwindinger WF, Levine MA. Genetic and molecular aspects of McCune-Albright syndrome[J]. Pediatr Endocrinol Rev, 2007,(S 4): 380-385. [4] Lumbroso S, Paris F, Sultan C. Activating Gsα mutations: analysis of 113 patients with signs of McCune-Albright syndrome—a European collaborative study[J]. J Clin Endocrinol Metab, 2004, 89(5): 2107-2113. [5] Liu Q, Sommer SS. PAP: detection of ultra rare mutations depends on P* oligonucleotides:“sleeping beauties” awakened by the kiss of pyrophosphorolysis[J]. Hum Mutat, 2004, 23(5): 426-436. [6] Liu Q, Sommer SS. Detection of extremely rare alleles by bidirectional pyrophosphorolysis-activated polymerization allele-specific amplification (Bi-PAP-A): measurement of mutation load in mammalian tissues[J]. Biotechniques, 2004, 36(1): 156-167. [7] Liu Q, Sommer SS. Pyrophosphorolysis-activated polymerization (PAP): application to allele-specific amplification[J]. Biotechniques, 2000, 29(5): 1072-1083. [8] Liu Q, Sommer SS. Pyrophosphorolysis-activatable oligonucleotides may facilitate detection of rare alleles, mutation scanning and analysis of chromatin structures[J]. Nucleic Acids Res, 2002, 30(2): 598-604. [9] Maat W, Kilic E, Luyten GP, et al. Pyrophosphorolysis detects B-RAF mutations in primary ureal melanoma[J]. Invest Ophthalmol Vis Sci, 2008, 49(1): 23-27. [10] Phylipsen M, Yamsri S, Treffers EE, et al. Non-invasive prenatal diagnosis of beta-thalassemia and sickle-cell disease using pyrophosphorolysis-activated polymerization and melting curve analysis[J]. Prenat Diagn, 2012, 32(6): 578-587. [11] Shi J, Liu Q, Sommer SS. Detection of ultrarare somatic mutation in the human TP53 gene by bidirectional pyrophosphorolysis-activated polymerization allele-specific amplification[J]. Hum Mutat, 2007, 28(2): 131-136. [12] Boon EM, Schlecht HB, Martin P, et al. Y chromosome detection by real time PCR and pyrophosphorolysis-activated polymerisation using free fetal DNA isolated from maternal plasma[J]. Prenat Diagn, 2007, 27(10): 932-937. [13] 郭奇伟,周裕林. 利用母血胎儿游离 DNA 进行单基因病无创产前诊断研究进展[J]. 中华医学遗传学杂志, 2009, 26(4): 410-413. [14] Narumi S, Matsuo K, Ishii T, et al. Quantitative and sensitive detection of GNAS mutations causing McCune-Albright syndrome with next generation sequencing[J]. PloS One, 2013, 8(3): e60525. [15] Dumitrescu CE,Collins MT. McCune-Albright syndrome[J]. Orphanet J Rare Dis, 2008, 3(5): 1-12. [16] Kalfa N, Philibert P, Audran F, et al. Searching for somatic mutations in McCune-Albright syndrome: a comparative study of the peptidic nucleic acid versus the nested PCR method based on 148 DNA samples[J]. Eur J Endocrinol, 2006, 155(6): 839-843. [17] Lietman SA, Ding C, Levine MA. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia[J]. J Bone Joint Surg Am, 2005, 87(11): 2489-2494. |